I am not sure I would expect to see those details in Investor Preso. The company has always been pretty thorough in highlighting this information in the annual report.
While I am not sure that the preso should have been classified as price sensitive there is a lot of new info in it that helps one to better understand the business. I think it is good to understand historically what percentage of business won in a year is invoiced in that year. On that basis I reckon we are going to be looking at a stonking year next year. We sort of know that at US$ 30 million of revenue we are profitable. Our contracted backlog for FY22 is likely to be in the US$ 30 - 32 million range by year end. On top of that and using historical precedent we should be looking at least another US$ 10 million revenues won and invoiced next year. That takes us to US$ 40/42 million in revenue. So we should be looking at EBITDA profit of at least US$ 8 million next year. Gives me comfort in my low teen P/EBITDA forecast for the next 12 months.
CGS Price at posting:
91.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)